Plasmapheresis in the dysproteinemias.

Area of Science:

• Hematology
• Immunology
• Internal Medicine

Background:

• Dysproteinemias are a group of diseases characterized by the overproduction of abnormal paraproteins.
• Clinical manifestations vary based on the affected organ systems and the nature of the paraprotein.
• Included conditions encompass cryoprotein-related diseases, Waldenström's macroglobulinemia, hyperviscosity syndrome, monoclonal gammopathy, multiple myeloma, light chain disease, and amyloidosis.

Purpose of the Study:

• To review the spectrum of dysproteinemias and their associated clinical syndromes.
• To elucidate the rationale and efficacy of plasmapheresis in managing these disorders.
• To discuss treatment strategies, including plasmapheresis schedules and adjunctive therapies.

Main Methods:

• Review of published studies, case reports, and clinical experience.
• Description of various dysproteinemia classifications and their pathophysiology.
• Explanation of plasmapheresis techniques: automated centrifugation, membrane separation, and immunoadsorption.

Main Results:

• Plasmapheresis is a widely used therapeutic modality for dysproteinemias, often combined with other treatments.
• Different plasmapheresis methods (automated, membrane, immunoadsorption) offer varying degrees of selectivity in removing pathogenic proteins.
• Treatment efficacy is supported by published data and clinical observations.

Conclusions:

• Plasmapheresis is a crucial intervention for managing the diverse clinical syndromes arising from dysproteinemias.
• Understanding the specific disease, paraprotein, and affected organs guides the selection of plasmapheresis technique and adjunctive therapies.
• This review provides a comprehensive overview for clinicians managing patients with these complex hematologic disorders.